Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Signe Holm

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
RMD Open|January 10, 2024
Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkersHelena Port, Frederik Christiansen, Signe Holm Nielsen, et al.
Rheumatology and Therapy|March 30, 2022
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)Georg Schett, Matthew J Loza, Arumugam Palanichamy, et al.
Arthritis Research & Therapy|December 23, 2022
Levels of extracellular matrix metabolites are associated with changes in Ankylosing Spondylitis Disease Activity Score and MRI inflammation scores in patients with axial spondyloarthritis during TNF inhibitor therapySigne Holm Nielsen, Shu Sun, Anne C Bay-Jensen, et al.
RMD Open|December 30, 2022
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritisChun Wu, Yanhua Hu, Peter Schafer, et al.
Plos One|March 17, 2023
Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuriaChristina Gjerlev Poulsen, Daniel G K Rasmussen, Federica Genovese, et al.
Osteoarthritis and Cartilage Open|December 7, 2022
A serological type II collagen neoepitope biomarker reflects cartilage breakdown in patients with osteoarthritisSolveig Skovlund Groen, Dovile Sinkeviciute, Anne-Christine Bay-Jensen, et al.
Respiratory Research|June 25, 2026
Fibroblast activity biomarkers are associated with mortality in severe COVID-19: a post-hoc analysis of a phase 2 clinical trialHelene Wallem Breisnes, Filipa Bica Simões, Peder Frederiksen, et al.
Pulmonary Circulation|April 19, 2019
Pressure overload induced right ventricular remodeling is not attenuated by the anti-fibrotic agent pirfenidoneStine Andersen, Julie Birkmose Axelsen, Steffen Ringgaard, et al.
Scientific Reports|April 5, 2020
A Fragment of Collagen Type VI alpha-3 chain is Elevated in Serum from Patients with Gastrointestinal DisordersSigne Holm Nielsen, Joachim Høg Mortensen, Nicholas Willumsen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2020
Collagen biology and non-invasive biomarkers of liver fibrosisMorten A Karsdal, Samuel J Daniels, Signe Holm Nielsen, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
RMD Open|January 10, 2024
Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkersHelena Port, Frederik Christiansen, Signe Holm Nielsen, et al.
Rheumatology and Therapy|March 30, 2022
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)Georg Schett, Matthew J Loza, Arumugam Palanichamy, et al.
Arthritis Research & Therapy|December 23, 2022
Levels of extracellular matrix metabolites are associated with changes in Ankylosing Spondylitis Disease Activity Score and MRI inflammation scores in patients with axial spondyloarthritis during TNF inhibitor therapySigne Holm Nielsen, Shu Sun, Anne C Bay-Jensen, et al.
RMD Open|December 30, 2022
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritisChun Wu, Yanhua Hu, Peter Schafer, et al.
Plos One|March 17, 2023
Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuriaChristina Gjerlev Poulsen, Daniel G K Rasmussen, Federica Genovese, et al.
Osteoarthritis and Cartilage Open|December 7, 2022
A serological type II collagen neoepitope biomarker reflects cartilage breakdown in patients with osteoarthritisSolveig Skovlund Groen, Dovile Sinkeviciute, Anne-Christine Bay-Jensen, et al.
Respiratory Research|June 25, 2026
Fibroblast activity biomarkers are associated with mortality in severe COVID-19: a post-hoc analysis of a phase 2 clinical trialHelene Wallem Breisnes, Filipa Bica Simões, Peder Frederiksen, et al.
Pulmonary Circulation|April 19, 2019
Pressure overload induced right ventricular remodeling is not attenuated by the anti-fibrotic agent pirfenidoneStine Andersen, Julie Birkmose Axelsen, Steffen Ringgaard, et al.
Scientific Reports|April 5, 2020
A Fragment of Collagen Type VI alpha-3 chain is Elevated in Serum from Patients with Gastrointestinal DisordersSigne Holm Nielsen, Joachim Høg Mortensen, Nicholas Willumsen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2020
Collagen biology and non-invasive biomarkers of liver fibrosisMorten A Karsdal, Samuel J Daniels, Signe Holm Nielsen, et al.
Pageof 10